Skip to main content

Table 2 Clinical variables in PCa and non-PCa patients

From: Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml

 

Prostate cancer

Non-PCa

p value

Total (n)

207

548

 

 4.0–10.0

96

369

 

 10.1–20.0

111

179

 

Age (year)

67.20 ± 8.78

63.92 ± 9.28

0.732

DRE positive (n)

65

73

< 0.001

PSA (ng/ml)

10.68 ± 4.05

9.09 ± 3.40

< 0.001

TPV (ml)

39.21 ± 15.29

54.88 ± 24.30

< 0.001

TZV (ml)

23.15 ± 12.34

35.27 ± 20.20

< 0.001

PSAD (ng/ml/ml)

0.31 ± 0.17

0.18 ± 0.09

< 0.001

TZPSAD (ng/ml/ml)

0.60 ± 0.49

0.33 ± 0.21

< 0.001

  1. TPV total prostate volume, TZV transition zone volume, PSAD PSA density, TZPSAD transition zone PSA density, PCa prostate cancer
Back to article page

BMC Urology

ISSN: 1471-2490

Contact us